HLB Pharmaceutical Co., Ltd. (047920.KQ) — Stock Score Summary

HLB Pharmaceutical Co., Ltd. (047920.KQ) has a MoatMap StockRank of 18/100 based on Quality (37/100), Value (38/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL. A South Korean pharmaceutical company with volatile earnings and high valuation. It lacks the global scale, proprietary moat, and consistent free cash flow required by the Buffett and Terry Smith lenses.

HLB Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company engaged in the development, manufacture, and distribution of prescription drugs, OTC medicines, and health supplements. The company's competitive advantage lies in its specialized drug delivery technologies and its integration into the broader HLB Group's global oncology pipeline. It operates as a mid-sized, diversified pharmaceutical player with growing capabilities in contract manufacturing (CMO).

Key Financial Metrics

Price$6.98
Market Cap$257M
P/E (TTM)75.60
Price/Book2.79
Return on Equity-39.8%
Return on Invested Capital4.4%
Debt/Equity13.39
Gross Margin7.8%
Operating Margin1.6%
Revenue Growth89.5%
Free Cash Flow$-530.32

HLB Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is HLB Pharmaceutical Co., Ltd.’s (047920.KQ) StockRank?
MoatMap’s StockRank for HLB Pharmaceutical Co., Ltd. (047920.KQ) is 18/100, with a Strong Sell signal. It is a composite of Quality (37), Value (38), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does HLB Pharmaceutical Co., Ltd. have an economic moat?
HLB Pharmaceutical Co., Ltd. (047920.KQ) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is HLB Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for HLB Pharmaceutical Co., Ltd. (047920.KQ) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is HLB Pharmaceutical Co., Ltd. in?
HLB Pharmaceutical Co., Ltd. (047920.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks047920.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock